Definitive Healthcare Q2 2024 Adj. EPS $0.09, Inline, Sales $63.737M Beat $62.909M Estimate
Portfolio Pulse from Benzinga Newsdesk
Definitive Healthcare (NASDAQ:DH) reported Q2 2024 earnings per share of $0.09, meeting analyst expectations. The company also reported sales of $63.737 million, surpassing the $62.909 million estimate and marking a 4.56% increase from the previous year.
August 05, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Definitive Healthcare reported Q2 2024 earnings per share of $0.09, in line with analyst expectations, and sales of $63.737 million, beating estimates by 1.32%. This represents a 4.56% increase in sales year-over-year.
The company's earnings per share met expectations, which is neutral news. However, the sales beat and year-over-year growth are positive indicators, likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100